InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Kulkarni Sandeep Chidambar. Director active across 2 companies, notably Tourmaline Bio, Inc.. In total, 8 reports have been recorded. Split: 5 buys · 0 sell. Total volume traded: €199k. History available since 24 October 2023. The latest transaction was filed on 22 October 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Kulkarni Sandeep Chidambar is linked to Tourmaline Bio, Inc., where he is CEO, and to Amanat Acquisition Corp., where he is Director and Chairman. Across 6 filings in total, the 6 sampled filings run from 2023-10-23 to 2026-05-22, with EUR 198783 in buys and EUR 0 in sells, and the dominant transaction nature is Acquisition.